Welcome to Bio-Babel

Working across disciplines can be confusing, not only due to professional jargon but also due to basic terminology being used interchangeably by different people or media sources. This is very true in the biomedical sphere. After a recent brief exchange with someone who is interested in technology applications in healthcare and life sciences, I was stimulated to propound some of […]

Blue Steens in October 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, more interesting new test kits have emerged; remdesivir gained FDA approval, yet trial interpretations are still a mixed bag; and vaccine development remains a global […]

Blue Steens in Aug-Sep 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, test kits are becoming more elaborate; repurposed drugs promise to accelerate recovery; and vaccine development is in full swing globally with Russia having already approved […]

Blue Steens in July 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, hydroxychloroquine as a potential treatment has fallen further from favour whilst remdesivir is in high demand; dexamethasone has also stood its ground; 4 highly promising […]

Blue Steens in June 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, we’ve seen interesting technologies being added to the spectrum of testing capabilities; hydroxychloroquine as a potential treatment seems to be falling from favour whilst remdesivir […]

Blue Steens in May 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance We’ve seen more reliable COVID-19 serological tests coming out on the market as well as clinical trials commencing and early results being released. Quite a few virtual events have […]

The winding path from lab to patient

Despite potential short-cuts, drug development is a lengthy and risky process that culminates in marketing approval. However, just because a drug achieves regulatory approval, does not mean that it will be instantly available to those in need. The complex journey for a pharmaceutical to gain patient access continues.

Federated learning in healthcare

What is federated learning? Federated learning (FL) is a machine learning paradigm that allows to train algorithms collaboratively without the need for source data exchange between the parties. This means that different institutions or companies can join forces in the development of data-driven solutions without sharing their secrets. Participants in such a venture come together in an FL consortium. How […]